2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1337):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-133059
    MRZ-8676
    MRZ-8676 is an active compound.
    MRZ-8676
  • HY-117077
    A70450
    A70450 is an active compound.
    A70450
  • HY-N7557
    (E)-2'-Hydroxy-3,4-dimethoxychalcone
    (E)-2'-Hydroxy-3,4-dimethoxychalcone (compound 7) is a Chalcone derivative with orally active. (E)-2'-Hydroxy-3,4-dimethoxychalcone has anti-tumour activities.
    (E)-2'-Hydroxy-3,4-dimethoxychalcone
  • HY-121776
    Nicomol
    		98.40%
    Nicomol is an orally active hypolipidemic agent that can increase the high density lipoprotein cholesterol (HDL-C) level. Nicomol inhibits the rapid rise of plasma free fatty acids.
    Nicomol
  • HY-113733
    ICI-195739
    ICI-195739 is an active compound.
    ICI-195739
  • HY-113743
    Ecomustine
    Ecomustine (CY233) is a nitrosoureido sugar derived from acosamine. Ecomustine shows antitumour activity.
    Ecomustine
  • HY-118248
    HW 173
    HW 173 is an active compound.
    HW 173
  • HY-120219
    TU-2100
    TU-2100 is an active compound.
    TU-2100
  • HY-19239
    FP-21399
    FP-21399 is an active compound.
    FP-21399
  • HY-113716
    Adecypenol
    Adecypenol is an active compound.
    Adecypenol
  • HY-119268
    Thiosildenafil
    Thiosildenafil, a Sildenafil (HY-15025) analogue, is a compound found in health supplement.
    Thiosildenafil
  • HY-131721
    14,15-EET-SI
    14,15-EET-SI is a sulfonimide (SI) analog metabolized from 14,15-EET, which is also an effective mitogen. 14,15-EET-SI can stimulate the incorporation of [3H] thymidine, activate pp60c-src and initiate the tyrosine kinase cascade, mediating their mitotic effects. Additionally, 14,15-EET-SI can increase cell proliferation as well as the expression of c-fos and egr-1 mRNA.
    14,15-EET-SI
  • HY-169784
    PPI-1040
    PPI-1040 is a synthetic PlsEtn, a precursor of plasmalogens. PPI-1040 is an orally available plasmalogen analog that increases plasmalogen in several peripheral tissues of Pex7 low allele mice. PPI-1040 has the potential to replace deficient plasmalogen and inhibit chondrodysplasia punctata (RCDP).
    PPI-1040
  • HY-127030
    Zatosetron
    Zatosetron is an active compound.
    Zatosetron
  • HY-P4671
    Nle-Arg-Phe-NH2 acetate
    Nle-Arg-Phe-NH2 (acetate) is a tripeptide compound, usually in the form of acetate.
    Nle-Arg-Phe-NH2 acetate
  • HY-114924
    LY465608
    LY465608 is an active compound.
    LY465608
  • HY-129645
    L-647318
    L-647318 is an active compound.
    L-647318
  • HY-119508
    Propaphos
    Propaphos is an active compound.
    Propaphos
  • HY-114912
    Benzoadenosine
    Benzoadenosine is an active compound.
    Benzoadenosine
  • HY-114542
    LY 201409
    LY 201409 is an anticonvulsant compound that is an analog of LY-201116 (HY-114705) with improved metabolic activity. LY 201409 antagonizes maximal electroconvulsive-induced seizures, has mixed effects on seizures induced by multiple chemoconvulsants, and affects behavior and sleep in mice.
    LY 201409